As global markets navigate mixed signals, with the S&P 500 Index capping off a strong two-year stretch despite recent profit-taking and economic uncertainties like the Chicago PMI’s contraction, investors are increasingly on the lookout for opportunities that may be undervalued. In such an environment, identifying stocks trading below their estimated value can be particularly appealing, as these investments might offer potential upside when market conditions stabilize or improve.
|
Name |
Current Price |
Fair Value (Est) |
Discount (Est) |
|
Avant Group (TSE:3836) |
¥1878.00 |
¥3755.66 |
50% |
|
NBTM New Materials Group (SHSE:600114) |
CN¥15.55 |
CN¥31.07 |
49.9% |
|
Gaming Realms (AIM:GMR) |
£0.36 |
£0.72 |
49.9% |
|
Sudarshan Chemical Industries (BSE:506655) |
₹1120.30 |
₹2232.36 |
49.8% |
|
Kinaxis (TSX:KXS) |
CA$170.99 |
CA$340.11 |
49.7% |
|
ReadyTech Holdings (ASX:RDY) |
A$3.15 |
A$6.30 |
50% |
|
Vogo (ENXTPA:ALVGO) |
€2.94 |
€5.87 |
49.9% |
|
Exosens (ENXTPA:EXENS) |
€22.505 |
€44.77 |
49.7% |
|
iFLYTEKLTD (SZSE:002230) |
CN¥45.41 |
CN¥90.65 |
49.9% |
|
Salmones Camanchaca (SNSE:SALMOCAM) |
CLP2434.90 |
CLP4848.26 |
49.8% |
Let’s uncover some gems from our specialized screener.
Overview: Daeduck Electronics Co., Ltd. is a company that provides various printed circuit boards (PCB) in South Korea and internationally, with a market cap of ₩847.26 billion.
Operations: The company’s revenue is primarily derived from its manufacture and sale of printed circuit boards, amounting to ₩920.01 billion.
Estimated Discount To Fair Value: 40.1%
DAEDUCK ELECTRONICS appears undervalued, trading at ₩16,800, which is 40.1% below its estimated fair value of ₩28,031.16. Despite lower profit margins this year (2.6% vs. 4.3% last year), earnings are forecast to grow significantly at 58% annually over the next three years, surpassing market expectations of 29%. However, revenue growth is moderate at 13.2%, and the dividend track record remains unstable amidst these promising cash flow indicators.
Overview: Dr. Soliman Abdel Kader Fakeeh Hospital Company operates and manages hospitals, clinics, and medical educational centers in Saudi Arabia with a market cap of SAR15.76 billion.
Operations: The company’s revenue segments consist of Education (SAR111.78 million), Medical Services (SAR2.53 billion), and Trading, Retail & Others (SAR222.64 million).
